Adipogenesis is a complex process governed by multiple signaling cascades operating through various regulatory factors and specific downstream genes. Here we identified TIS7 (IFRD1) and its orthologue SKMc15 (IFRD2) as new regulators of adipogenesis and fat metabolism. Mice deficient in both TIS7 and SKMc15 (dKO) had severely reduced adipose tissue and were resistant to diet-induced obesity. Wnt signaling, a negative regulator of adipocyte differentiation, was significantly up regulated in TIS7 SKMc15 dKO mice. Elevated levels of the Wnt/β-catenin target protein Dlk-1 inhibited the expression of adipogenesis regulators PPAR and C/EBP, and fatty acid transporter CD36.
Introduction
Novel approaches for treating obesity-related conditions depend on the understanding of adipogenesis as a complex process in which multipotent stem cells are converted to preadipocytes before terminal differentiation into adipocytes 1 . The mechanisms that promote preadipocyte commitment and maturation involve protein factor regulators, epigenetic factors, and miRNAs. Detailed characterization of this process is therefore currently an area of intense research. TPA Induced Sequence 7 (TIS7) protein has been shown to be involved in the mainly transcriptional regulation of differentiation processes in various cell types, e.g. neurons 2, 3 , enterocytes 4 , myocytes 5, 6 and also adipocytes 7 .
Multiple lines of evidence link the regulation of Wnt/-catenin signaling to the physiological function of TIS7 8 , known in human as Interferon related developmental regulator 1 (IFRD1) 7, 9, 10 . TIS7 deficiency leads to a significant up regulation of Wnt/-catenin transcriptional activity in both primary osteoblasts and in mouse embryonic fibroblasts (MEFs) derived from TIS7 knockout mice 9, 10 . Recent data show that TIS7 is also involved in the control of adipocytes differentiation in mice 7 . TIS7 was found to be up regulated in both visceral (vWAT) and subcutaneous (sWAT) white adipose tissues (WAT) of genetically obese ob/ob mice 7 . TIS7 transgenic mice have increased total body adiposity and decreased lean mass compared with normal littermates 4 . On HFD, TIS7 transgenic mice exhibit a more rapid and proportionately greater gain in body weight with persistently elevated total body adiposity 4 . Enhanced triglyceride (TG) absorption in the gut of TIS7 transgenic mice 4 indicated that TIS7 expressed in the gut epithelium has direct effects on fat absorption in enterocytes. On the other hand, we have shown that as a result of impaired intestinal lipid absorption TIS7 knockout mice displayed lower body adiposity 11 . Compared with wild type (WT) littermates, TIS7 knockout mice do not gain weight when chronically fed a HFD and TIS7 deletion results in delayed lipid absorption and altered intestinal and hepatic lipid trafficking, with reduced intestinal TG, cholesterol, and free fatty acid mucosal levels in the jejunum 11, 12 . However, at this point, the precise mechanism of TIS7 action in the regulation of lipid absorption and metabolism on the molecular level was unclear. TIS7 protein functions as a transcriptional co-regulator 13 due to its interaction with protein complexes containing either histone deacetylases (HDAC) 6, 9, [14] [15] [16] or protein methyl transferases, in particular PRMT5 17 . The analysis of the adipocyte differentiation in preadipocytic 3T3-L1 cells suggested the involvement of TIS7 in the regulation of adipogenesis in the Wnt/-catenin signaling context 7 .
SKMc15, also known as Interferon related developmental regulator 2 (IFRD2), a second member of TIS7 gene family, is highly conserved in different species 18 . Mouse TIS7 and SKMc15 are highly homologous, with a remarkable identity at both the cDNA and amino acid levels (58% and 88%, respectively). However, there is so far no information about the physiological function and mechanisms of action of SKMc15 and its possible involvement in differentiation of various tissues remains to be studied.
Adipogenesis occurs late in embryonic development and in postnatal periods. Adipogenic transcription factors CCAAT/enhancer binding protein  (C/EBP) and peroxisome proliferator activated receptor  (PPAR) play critical roles in adipogenesis and in the induction of adipocyte markers [19] [20] . PPARγ is the major downstream target of Deltalike protein 1 (DLK-1). It is turned off by the induction of the MEK/ERK pathway leading to its phosphorylation and proteolytic degradation 21 . DLK-1, also known as Pref-1 (preadipocyte factor 1) activates the MEK/ERK pathway to inhibit adipocyte differentiation 22 . C/EBPα that is highly expressed in mature adipocytes 23 can bind DNA and together with PPARγ to a variety of respective target genes 23 . Besides that, PPARγ binding to C/EBPα induces its transcription, thereby creating a positive feedback loop 24 . These two proteins have synergistic effects on the differentiation of adipocytes that requires a balanced expression of both C/EBPα and PPARγ 23 .
One of the extracellular signaling pathways known to specifically affect adipogenesis is the Wnt/-catenin signaling pathway [25] [26] [27] [28] [29] . Wnt signaling maintains preadipocytes in an undifferentiated state through inhibition of C/EBP and PPAR 20, 30, 31 . PPAR-γ and Wnt/β-catenin pathways are regarded as master mediators of adipogenesis 32 . Wnt signaling is a progenitor fate determinator and negatively regulates preadipocyte proliferation through DLK-1 [33] [34] [35] . Mice over-expressing DLK-1 are resistant to HFD-induced obesity, whereas DLK-1 knockout mice have accelerated adiposity 33 . DLK-1 transgenic mice show reduced expression of genes controlling lipid import (CD36) and synthesis (Srebp1c, Pparγ) 36 . The DLK-1 expression coincides with an altered recruitment of the protein methyl transferase 5 (PRMT5) and -catenin to the DLK-1 promoter 37 . PRMT5 acts as a co-activator of adipogenic gene expression and differentiation 38 . SRY (sex determining region Y)-box 9 (Sox9), a transcription factor expressed in preadipocytes, is down regulated preceding adipocyte differentiation 39 . DLK-1 prevents down regulation of Sox9 by activating ERK, resulting in inhibition of adipogenesis 39 . The PRMT5-and histone-associated protein COPR5, affects PRMT5 functions related to cell differentiation 40 . Adipogenic conversion is delayed in MEFs derived from COPR5 KO mice 37 and WAT of COPR5 knockout mice is reduced when compared to control mice. DLK-1 expression is up regulated in COPR5 knockout cells 37 .
Here we show for the first time that TIS7 and SKMc15, two members of a gene family, regulate not only intestinal lipid absorption, but mainly the process of adipocyte differentiation. TIS7 SKMc15 double knockout (dKO) mice had strongly decreased amounts of the body fat when fed with even regular, chow diet. We found two independent molecular mechanisms through which TIS7 and SKMc15 fulfill this function in a synergistic manner. TIS7 regulates the Wnt signaling pathway activity and thereby restricts DLK-1 protein levels allowing adipocyte differentiation. In contrast to that, SKMc15 knockout did not affect Wnt signaling. Importantly, dKO mice displayed a dominantly leaner phenotype when compared to TIS7 single knockout mice. The ablation of both TIS7 and SKMc15 genes was accompanied by a decrease in genes essential for adipocyte differentiation and function. Since TIS7 SKMc15 dKO mice render a substantially leaner phenotype on chow diet, without any challenge by HFD-induction, we propose that TIS7 and SKMc15 represent novel players in the process of physiological adipocyte differentiation and fat uptake in the intestines.
Results

Mice lacking TIS7 and SKMc15 genes have lower body mass, less fat and are resistant against HFD-induced obesity.
To identify a potential role of the TIS7 orthologous protein SKMc15 in pathophysiological processes, we generated SKMc15 KO mice (Supplementary figure 1) . These mice were viable and fertile, but significantly (p<0.001) smaller than their WT littermates (body mass; Supplementary figure 2a) and mainly, as determined by Dual Energy X-ray Absorptiometry (DEXA), they had reduced fat mass (Supplementary figure 2b) . On the contrary, the total body mass of TIS7 single KO mice was slightly (-5.1 %), but not significantly lower than the WT. In order to clarify whether both, TIS7 and SKMc15 are involved in the regulation of the adipocyte differentiation and/or the fat metabolism and if they act through same or different mechanisms, we have generated mice lacking both TIS7 and SKMc15 genes by crossing TIS7 with SKMc15 single KO mice. Double heterozygous mice were mated and the pups were genotyped by PCR.
The genotype of the analyzed pups corresponded to the predicted Mendelian distribution. However, the number of pups born per litter was significantly lower (P<0.01) when compared to their WT littermates (Supplementary figure 2c). dKO pups were viable, and adult male and female mice were fertile. At birth the body weight of dKO and WT littermate mice were similar. Nevertheless, already during the weaning period, both the male and female dKO mice failed to gain weight when compared to their WT littermates. The reduced body weight gain persisted in the following weeks when the mice were fed regular diet (RD; chow diet) containing 11 % kcal of fat (Figure 1a ). At 10 weeks of age, both male and female dKO mice displayed 30 % and later up to 44.9 % lower body weight compared with WT mice. Thus, ablation of TIS7 and SKMc15 genes resulted in strong reduction of body weight of mice kept on regular diet. These data suggested that TIS7 and SKMc15 do not play a role in the growth regulation during the prenatal development, but most probably affect postnatal fat uptake and/or adipocyte differentiation.
DEXA was performed to assess the total body fat content of dKO mice. 6-month-old WT mice had substantially higher amounts of fat than their dKO littermates, i.e. the percentage of fat was in the WT mice 37.7 ± 4 % vs. 6 ± 3 % of the total body mass in dKO animals. Furthermore, the percentage of lean tissue mass in WT animals was lower than in dKO animals (60 ± 4.6 % vs. 92 ± 3.14 %; Figure 1b ). Next, we have analyzed the contribution of TIS7 and SKMc15 to the whole-body fat content of mice. 3-dimensional reconstitution images based on micro-computed tomography (micro-CT) technology disclosed that both TIS7 and SKMc15 KO mice had less abdominal fat than WT controls and mainly that the double knockout of both TIS7 and SKMc15 genes caused the strongest decrease in both, abdominal fat content and size ( Figure 1c ). The quantitative analyses of micro-CT analyses confirmed previous measurements showing that TIS7 deficiency caused a substantial lack of the abdominal fat tissues (P=0.002 when compared to WT mice). Whereas TIS7 knockout mice had less fat mass but were not significantly smaller (P=0.068) than their WT littermates, SKMc15 knockout were smaller (P=0.007) and leaner (P=0.0001) and dKO mice were highly significantly smaller (P = 0.0001) and had significantly less abdominal fat (P=0.006) than the WT mice ( Figure 1d ). Given the differences in body weight and adiposity we conducted an indirect calorimetry (IC) trial monitoring over 21 hours gas exchange (oxygen consumption and carbon dioxide production), activity (distance and rearing), and food intake with sex-and age-matched WT and dKO animals. We measured body mass before and after the trial and determined rectal body temperature. Food intake and energy expenditure were analyzed using a linear model including body mass as a covariate. Rectal body temperature determined after the IC trial did not differ (36.56 WT and 36.71 dKO mice). The typical daily pattern of oxygen consumption during the IC trial was observed in WT and dKO mice.
Mean oxygen consumption correlated with the different body masses of WT and dKO mice. Maximal oxygen consumption (VO2) values were lower in the dKO mice (81.12 ml/l vs. 107.28 in WT mice). However, when adjusted to the body mass difference, they corresponded well to the reduced body mass. Using this approach, no genotype effect on oxygen consumption could be detected. There was also no substantial genotype effect on food intake, although when adjusted to the body mass this was non-significantly increased in dKO mice (4.0 g WT and 3.4 g dKO mice).
Apart from minor differences observed during the first hours of the trial, respiratory exchange ratios (RER = VCO2/VO2) were identical in WT and dKO mice (Supplementary figure 3a) . Concerning the activity, no effects could be detected in the total travelled distance (928 cm/20 min WT and 874 cm/20 min dKO mice) and rearing behavior (116 rearing/20 min WT and 96 rearing/20 min dKO mice). In summary, in TIS7 SKMc15 dKO mice we have identified substantially reduced body weight, mainly because of lacking fat. These differences were found despite the identical food intake, activity and no major differences in several metabolic parameters.
To investigate potential links between TIS7, SKMc15 and obesity, we studied the response of dKO mice to HFD. At 2 months of age, male mice were housed individually and fed with HFD for 21 days. Food intake was measured every second day and body weight was measured every fourth day. Feces were collected every second day to analyze the composition of excreted lipids and blood samples were collected after the third week of HFD feeding to measure the concentrations of hepatic and lipoprotein lipases, respectively. Already within the first week of HFD feeding, WT mice gained more weight than the dKO mice ( Figure 1e ), although there were no obvious differences in food consumption (Supplementary figure 3c) or in levels of lipolytic enzymes (Supplementary figures 3d, e). These differences in body weight gain continued to increase during the second and third week, at which time the body weight of WT mice increased additionally for 30% (30.0 ± 2.3%) when compared with the beginning of the HFD feeding period. In contrast, the weight of dKO animals increased only slightly (7.6 ± 1.6%) ( Figure 1e and Supplementary figure 2d ). Both genes, TIS7 and SKMc15 contributed to this phenotype and we could see an additive effect following their deletion ( Figure   1e ). Previous studies showed that intestinal over-expression of TIS7 caused increased intestinal lipid transport resulting in elevated body weight gain during HFD feeding 41 . To test the hypothesis that TIS7 and SKMc15 dKO impaired absorption of free fatty acids from the lumen into enterocytes we administered olive oil by oral gavages to HFD-fed WT and dKO mice. After one-week adaptation to HFD, there was lower TGs accumulation in the intestines of dKO mice (3 hours after bolus oil feeding) as detected by oil red O staining (Figure 2a ). To examine the kinetics of dietary fat entry into the serum, mice were orally given [ 3 H]-triolein. Radioactivity levels in plasma samples from dKO mice were rising markedly slower than those of WT mice (Figure 2b ), confirming a reduced rate of fat absorption from intestines into the circulation. Interestingly, while fed with HFD, dKO mice had higher concentrations of free fatty acids in the feces (109 ± 10.4 µmol/g) when compared to the WT animals (78 ± 6.5 µmol/g) ( Figure 2c ) and a consequent increase in feces energy content (WT: 14.442 ± 0.433 kJ/g dry mass compared to dKO: 15.497 ± 0.482 kJ/g dry mass, Figure 2d ). Thus, lack of TIS7 and SKMc15 reduced efficient free fatty acid uptake in the intestines of mice. Unexpectedly, dKO mice had increased postprandial serum TG levels (Figure 2e ). Furthermore, 4 hours after intragastric administration of olive oil dKO mice displayed an inability to clear TGs from the circulation (Supplementary figure 3b ). There was also a reduction of postprandial serum glucose levels in dKO mice (Figure 2f ), which remained up to 10 hours of the fasting period. Therefore, we investigated WT and dKO mice in an intraperitoneal glucose tolerance test. In contrast to WT mice, dKO mice had an increased ability to deal with a glucose load indicating an increased rate of blood glucose clearance ( Figure 2g ). Although our experiments suggested that dKO mice suffer from an intestinal lipid uptake deficiency, yet another contributing reason for the lean phenotype of dKO mice may be that TIS7 and SKMc15 regulate the adipocyte differentiation.
Adipocyte differentiation in TIS7 SKMc15 dKO mice is inhibited due to up regulated Wnt signaling and DLK-1 secretion regulated via β-catenin.
Primary MEFs derived from totipotent cells of early mouse mammalian embryos are capable of differentiating into adipocytes and they are versatile models to study adipogenesis as well as mechanisms related to obesity such as genes, transcription factors and signaling pathways implicated in the adipogenesis process 42 . To test whether TIS7 and SKMc15 are required for adipogenesis we treated MEFs derived from WT, SKMc15 and TIS7 single and dKO mice, using an established adipocyte differentiation protocol 41 Figure 3b ). These data indicated that both, TIS7 and SKMc15 were also equally critical for adipocyte differentiation. Furthermore, these results suggested that the defect in adipogenesis could be responsible for the resistance of dKO mice to HFD-induced obesity.
Wnt/β-catenin signaling is an important regulatory pathway for adipocyte differentiation 43, 28 . Consistently, others and we have shown that TIS7 deficiency causes up regulation of Wnt/-catenin transcriptional activity 9, 10 . Therefore, we have assessed Wnt signaling activity in MEFs by measuring transcriptional activity with TOPflash luciferase reporter assays. As shown in Figure 3c , Wnt signaling activity, when compared to the WT MEFs, was not regulated in SKMc15 KO, but significantly up regulated in TIS7 KO (8-fold increase; P<0.0001) and dKO MEFs (2-fold increase; P<0.01).
Next, we analyzed total β-catenin levels by Western blotting in 3 biological replicates of WAT from WT and dKO mice.
WAT of dKO showed 2 fold up regulation of β-catenin protein levels ( Figure 3d ) when compared to WT mice ( Figure   3d ). This suggested that TIS7 and SKMc15 may also affect levels of Wnt signaling target genes. Therefore, we further analyzed the expression of DLK-1, a negative regulator of adipogenesis and known target of Wnt signaling 37, 44 or as the co-expression of TIS7 and SKMc15 (P<0.05) ( Figure 3h ). Based on these data we concluded that TIS7 and SKMc15 are required to restrain the DLK-1 levels, most probably through the Wnt/-catenin signaling pathway.
DLK-1 protein has a protease cleavage site in its extracellular domain 45 and is secreted. Hence, adding soluble DLK-1 to the medium inhibits adipogenesis 44 . To test if the dKO MEFs secreted DLK-1, cell culture media from MEFs treated 8 days with the adipocyte differentiation cocktail were collected and analyzed by Western blotting. As shown in figure 3i, dKO secreted DLK-1 protein, but in an identical volume of the cell culture medium from WT MEFs no DLK-1 could be detected. To prove that secreted DLK-1 could inhibit adipocyte differentiation of dKO MEFs, we cultured WT MEFs with conditioned medium from dKO MEFs. Adipocyte differentiation of WT MEFs was strongly inhibited by the dKO MEFs-conditioned medium when compared to the control WT cells (Figure 3j ). Based on these results we concluded that tissues of TIS7 SKMc15 dKO mice and cells derived from those express increased DLK-1 levels and secreted, soluble DLK-1 may inhibit adipocyte differentiation in vivo.
According to the data presented above, TIS7 and/or SKMc15 are involved in the regulation of DLK-1 expression. Since the molecular requirements for this regulation were so far unresolved we proceeded with chromatin immunoprecipitation (ChIP) experiments, where we studied the binding of known and novel transcription factors to the DLK-1 regulatory region. Our earlier study showed that TIS7 directly binds to DNA and also regulates gene expression via PRMT5 17 . Therefore, we tested in DLK-1 ChIP experiments the direct binding of both TIS7 and SKMc15, as well as symmetrically dimethylated histones H4 and β-catenin, proteins involved in the transcriptional regulation of DLK-1 37 . We found increased β-catenin binding (P<0.0001) and reduced amounts of histone H4, symmetrically dimethylated at the arginine 3 residue at the DLK-1 regulatory element in dKO, but not in WT MEFs treated 8 days with the adipocyte differentiation cocktail ( Figure 3k ). However, neither in WT nor in dKO MEFs we could identify any direct binding of TIS7 or SKMc15 proteins to the DLK-1 regulatory elements. These results suggested that TIS7 and SKMc15 epigenetically regulate DLK-1 expression indirectly, i.e. affecting β-catenin levels and its binding to the DLK-1 regulatory region, rather than via their direct binding to DLK-1 regulatory elements.
TIS7 and SKMc15 regulate adipocyte differentiation through DLK-1, MEK/ERK pathway and adipogenic regulators
PPARγ and C/EBP.
Previous studies showed that soluble DLK-1 activates MEK/ERK signaling, which is required for inhibition of shown to up regulate the expression of the transcription factor SOX9, resulting in the inhibition of adipogenesis 39 .
Therefore, we measured SOX9 mRNA expression by RT qPCR in 8 days adipocyte-differentiated MEFs. SOX9 expression was highly significantly (P<0.001) up regulated in 8 days adipocyte-differentiated dKO when compared to WT MEFs (Figure 4c ).
The adipocyte differentiation deficiency of dKO MEFs suggested that C/EBPα and PPARγ might also be regulated through TIS7 and/or SKMc15. It was previously shown that DLK-1 activates the MEK/ERK pathway 22 and furthermore that elevated levels of the cleaved ectodomain of DLK1 have been correlated with reduced expression of PPARγ 46, 47 .
Therefore, we analyzed the differences in PPARγ expression between WT and dKO MEFs during their differentiation into adipocytes. As long as PPARγ expression was strongly induced during WT MEFs adipocyte differentiation this was barely detectable in dKO MEFs (Figure 4d ). Also C/EBPα expression in TIS7/SKMc15 dKO MEFs stayed low and was never induced up to the levels of WT (Figure 4e ). In a rescue experiment we showed that the co-expression of TIS7 and SKMc15 strongly increased the expression of the PPARγ in dKO MEFs (P<0.001), almost up to the levels of WT MEFs (Figure 4f ). The expression of yet another adipogenic regulator C/EBPα was also strongly up regulated by the co-expression of TIS7 and SKMc15 (P<0.01) ( Figure 4g ). Based on these results we concluded that TIS7 and SKMc15 regulate the expression of both PPARγ and C/EBPα, two master regulator genes crucial for the adipocyte differentiation.
TIS7 and SKMc15 regulate the expression of the lipid transporters CD36 and DGAT1.
To determine whether decreased intestinal lipid absorption might be caused by changes in expression of lipid processing and transporting molecules, we performed transcriptome analyses of total RNA samples isolated from the small intestines of HFD-fed WT type and dKO animals. Cluster analyses of lipid transport-related gene transcripts revealed differences between WT type and dKO animals in the expression of adipogenesis regulators, such as peroxisome proliferator-activated receptors γ (PPARγ) and  48 , fatty acid binding proteins 1 and 2 (FABP1, 2) 49 , cytoplasmic fatty acid chaperones expressed in adipocytes, acyl-coenzyme A synthetases 1 and 4 (ACSL1,4) found to be associated with histone acetylation in adipocytes, lipid loading and insulin sensitivity 50 , SLC27a1, a2 fatty acid transport proteins, critical mediators of fatty acid metabolism 51 , angiotensin-converting enzyme (ACE) playing a regulatory role in adipogenesis and insulin resistance 52 , CROT, a carnitine acyltransferase important for the oxidation of fatty acids, a critical step in their metabolism 53 , phospholipase PLA2G5 robustly induced in adipocytes of obese mice [54] [55] [56] . Upon those, we decided to study in more detail the regulation of CD36 that encodes a very long chain fatty acids (VLCFA) transporter. The transmembrane protein CD36 is an important fatty acid transporter that facilitates a fatty acids (FA) uptake by heart, skeletal muscle, and also adipose tissues 57 . PPARγ induces CD36 expression in adipose tissue where it functions as a fatty acid transporter, and therefore, its regulation by PPARγ contributes to the control of blood lipids. Interestingly, CD36 null mice exhibit elevated circulating LCFA and triglycerides levels consistent with the phenotype of TIS7 SKMc15 dKO mice and CD36 deficiency partially protected from HFD-induced insulin resistance [57] [58] [59] . Using three different probe sets we identified a statistically significant down regulation of CD36 gene expression in the jejunum of dKO mice (2.1-, 2-, and 2.7-fold down regulation) (Figure 5a bottom). Reduced CD36 mRNA and protein levels in small intestines of dKO mice were independently confirmed in a larger cohort of animals (n=8; Figure 5b ). Immunohistochemical staining of CD36 in small intestines of HFD-fed mice showed a down regulation in the number of CD36-positive cells, as well as an in the signal intensity in enterocytes of dKO mice when compared to WT (Figure 5c ). These data correlated well with changes identified in CD36 mRNA and protein levels (Figure 5b ).
Since CD36 is expressed in the adipose tissues 60 we analyzed its expression in the WAT of WT and dKO mice. CD36 mRNA expression was strongly reduced in WAT from dKO mice (64 % of the WT values) ( Figure 5d ). Next, we analyzed CD36 in WT and dKO MEFs before the onset and during the adipocyte differentiation. As long as CD36 mRNA expression during the eight days of differentiation substantially increased in WT MEFs, there were almost undetectable transcript levels of CD36 in dKO cells treated with the adipocyte differentiation cocktail (Figure 5e ). Diacylglycerol acyltransferase 1 (DGAT1), a protein associated with the enterocytic triglyceride absorption and intracellular lipid processing [83] is besides CD36 another target gene of adipogenesis master regulator PPARγ 61 . DGAT1 mRNA levels are strongly up regulated during adipocyte differentiation 62 , its promoter region contains a PPARγ binding site [91] and DGAT1 is also negatively regulated by the MEK/ERK pathway [92] . DGAT1 expression was shown to be increased in TIS7 transgenic mice 4 and its expression was decreased in the gut of high fat diet-fed TIS7 KO mice 11 . Importantly, DGAT1 expression in adipocytes and WAT is up regulated by PPARγ activation 61 . Therefore, we measured DGAT1mRNA levels during the differentiation of WT and TIS7 SKMc15 dKO MEFs into adipocytes to analyze the role of TIS7 and SKMc15 on the regulation of this protein involved in adipogenesis and triglyceride processing. As long as DGAT1 expression substantially increased during the differentiation of WT MEFs, there was no difference in DGAT1 mRNA levels in dKO cells treated with the adipocyte differentiation cocktail (Figure 5f ). Based on these data we concluded that both, TIS7 and SKMc15 regulate expression of multiple proteins involved in fat uptake both in intestines and adipocytes thereby contributing to the lean phenotype of TIS7 SKMc15 dKO mice.
Discussion
In this study we show that simultaneous depletion of TIS7, a protein regulating cell differentiation 20, 30, 31 and of its orthologue SKMc15, a protein with until now unknown function caused in mice severe reduction of adipose tissues and resistance against high fat-induced obesity. We identified two parallel mechanisms leading to this strong phenotype.
Firstly, it was the lack of fat adsorption in small intestines and secondly a deficiency in the adipocyte differentiation. As mechanisms leading to these two phenomena we pinpointed the TIS7-regulated Wnt signaling pathway and yet another SKMc15-dependent regulatory mechanism, both controlling in parallel the DLK-1 protein levels ( Figure 6 ). TIS7 SKMc15 dKO mice were phenotypically similar with both, CD36 deficient and DLK-1 transgenic mice, namely in decreased amounts of WAT and resistance to HFD-induced obesity. Based on previous studies with TIS7 single knockout mice we knew that TIS7 ablation leads to resistance against HFD-induced obesity 11, 16 , increases Wnt signaling pathway activity and regulates PRMT5 towards the regulatory regions of target genes 16, 17 . Here we focused on the clarification of TIS7 and SKMc15 roles in the regulatory mechanisms of intestinal fat absorption and adipogenesis.
In TIS7 SKMc15 dKO mice we found inhibited PPARγ and C/EBPα levels, induced MEK/ERK pathway, and decreased expression of CD36 and DGAT1, all hallmarks of up regulated DLK-1. TIS7 and SKMc15 acted after the commitment to the preadipocyte stage since the elevated DLK-1 and β-catenin levels found in the white adipose tissue of TIS7 SKMc15 dKO mice are characteristic for the preadipocyte stage 44, 63 . In addition, the lipid transport deficiency of intestinal enterocytes due to their lower CD36 expression levels also led to the impaired fat accumulation in TIS7 SKMc15 dKO mice. The lack of intestinal CD36 caused higher secretion of free fatty acids, important building blocks of TG synthesis and also of fat accumulation in target tissues. TIS7 SKMc15 dKO mice helped us to understand the biological functions and potential synergisms of TIS7 and SKMc15 activities in vivo. During adipocyte differentiation of WT MEFs we have identified differential expression patterns for TIS7 and SKMc15. While TIS7 mRNA levels reached maximum values on day 3 of the adipocyte differentiation and its expression increased 6-fold when compared to the MEFs, SKMc15 reached expression plateau on day 5 and was 2.5-fold increased. These data suggested that both proteins play a regulatory role in adipogenesis, however differ in their mechanisms and timing. To further support this statement, our data show that TIS7 knockout strongly up regulated Wnt signaling whereas SKMc15 knockout had no effect. The disruption of Wnt signaling in embryonic fibroblasts results in spontaneous adipocyte differentiation 29, 64 and opposite, stabilized β-catenin keeps cells in the preadipocyte stage 29 . Consistent with this we found up regulated β-catenin protein levels in WAT of TIS7 SKMc15 dKO mice and increased Wnt signaling activity in TIS7 SKMc15 dKO MEFs. We demonstrated that increase in Wnt signaling lead to up regulated -catenin binding to the DLK-1 gene regulatory elements resulting in sustained DLK-1 expression in TIS7 SKMc15 dKO MEFs induced for adipocyte differentiation. In the adipogenesis is DLK-1 expression down regulated through histone methylation by COPR5 and PRMT5 that prevent -catenin binding to the DLK-1 gene 37 . Interestingly, we found that symmetric dimethylation of H4R3 at the DLK-1 promoter was reduced in dKO MEFs consistent with our previous findings on the role of TIS7 in epigenetic regulation 17 . There was a difference in effects of ectopic expression of TIS7, SKMc15 and their co-expression on DLK-1 levels, suggesting that TIS7 and SKMc15 might be involved in two independent pathways/mechanisms of DLK-1 transcriptional regulation. Despite the fact that SKMc15 knockout had no effect on Wnt signaling it also affected DLK-1 mRNA levels suggesting a contribution of SKMc15 to transcriptional regulation of this gene. Recently SKMc15 (IFRD2) was identified as a novel factor capable to translationally inactivate ribosomes 65 . Since down regulation of the protein synthesis machinery is essential regulatory event during early adipogenic differentiation 66 , it is possible that SKMc15 may also regulate DLK-1 protein levels through translational regulation, however additional investigations will be necessary. Elevated DLK-1 levels in TIS7 SKMc15 dKO MEFs activated the MEK/ERK pathway thereby decreasing PPARγ and C/EBPα levels important for adipogenic differentiation. Besides that, the expression of SOX9 was up regulated 22 , suggesting that the TIS7 SKMc15 dKO MEFs keep their proliferative state and cannot enter differentiation into mature adipocytes 22 .
Down regulation of PPARγ and C/EBPα implied changes in expression of downstream adipogenesis-related genes.
Among them, decreased CD36 and DGAT1 levels were a plausible explanation of the dKO mice lean phenotype since it is known that both proteins play a functional role in differentiation of murine adipocytes and their deficiency impairs fat pad formation independent of lipid uptake 67 . On the other hand, reduced CD36 expression might explain higher fecal free fatty acid concentrations and elevated serum TG levels due to reduced free fatty acid uptake in multiple cell types of TIS7 SKMc15 dKO mice. Moreover, CD36-deficient mice have phenotypical characteristics (resistance to HFD-induced obesity 68 ; impaired intestinal lipid uptake 69 ; higher plasma triglyceride levels, and lower plasma glucose levels 70 ) that are almost identical to our TIS7 SKMc15 dKO mice. Our findings implicate that TIS7 and SKMc15 play a role in the regulation of CD36 and therefore possibly contribute to CD36 related pathogenesis of human metabolic diseases, such as hypoglycemia 71 , hypertriglyceridemia 72 , and disordered fatty acid metabolism [73] [74] [75] . TIS7 SKMc15 dKO mice had under both, chow and HFD conditions decreased body weight. Comparing dKO with single knockout mice we showed that both TIS7 and SKMc15 contributed to this phenotype in a synergistic manner.
We also identified similar synergism of TIS7 and SKMc15 knockout effects on the body fat content. Our data presented here explain the phenotype on the molecular level and propose that TIS7 and SKMc15 regulated both, fat absorption in the small intestine and adipocytes differentiation. Because of high similarity between TIS7 and SKMc15 genes with their human IFRD1 and IFRD2 homologues our findings may be relevant for the treatment of obesity and related metabolic disorders. Generation of animal models. Mice lacking TIS7 were generated as previously described 6 designed to be specifically removed) were screened by PCR for the deleted allele. The cre recombinase-mediated deletion resulted into a gene product consisting of the SKMc15 WT promoter, exon 1, intron 1 (with inserted loxP site), 9 nucleotides of the exon 2, and additional 14 nucleotides for in-frame link to the hrGFP coding sequence. The hrGFP coding sequence was followed by 442 bp poly A tail and the SKMc15 wt locus continuing at the position 102078 (AY162905). PCR results were confirmed by Southern blot analysis. Clones in which the floxed gene part was successfully deleted, were used for blastocyst injection into C57Bl/6J recipient mice. We received two male chimeras for the deleted construct with ≥ 40 % or more agouti coat color. These chimeras were mated to C57Bl6 females for germ-line transmission. There was one case of successful germline transmission. Thus, the knockout mouse strain was derived from only one male mouse carrying the allele of interest. Heterozygous mice were more back-crossed to C57Bl6 mice to reduce the Sv129 genome fraction and after 9 generations mice were assumed to have a clean C57Bl6 background. TIS7 SKMc15 dKO mice were generated by crossing the SKMc15 knockout mice with the TIS7 single knockout mice 6 . The resulting mice were screened by PCR and double heterozygous mice used for further breeding until homozygosity. (Supplementary figure 1a) . The WT allele PCR product was 426 bp and the targeted allele PCR product was 1772 bp long (Supplementary figure 1b) . The SKMc15 deleted allele lacked the binding site for RG1 and therefore did not give any product. The genotype of TIS7 was tested as explained previously 6 Metabolic measurements. The indirect calorimetry trial monitoring gas exchange (oxygen consumption and carbon dioxide production), activity (distance and rearing), and food intake was conducted over a period of 21 hours (PhenoMaster TSE Systems GmbH, Bad Homburg, Germany). Body mass before and after the trial was measured and rectal body temperature (approximately at 10 AM, before transfer of mice back to their home cages, was measured). The genotype effects were statistically analyzed using 1 way ANOVA. Food intake and energy expenditure were analyzed using a linear model including body mass as a co-variate.
Methods
HFD feeding. Age-matched (7-10 week old) male TIS7-/-SKMc15-/-mice and WT controls were caged individually and maintained from 3 weeks up to 8 weeks on a synthetic, high saturated fat (HFD) diet (TD.88137; Ssniff); 42% kcal from milk fat, 0.2% kcal from cholesterol). Animals were weighted every 4th day between 08:00 and 10:00. Small intestines were harvested for oil red O staining to detect lipid accumulation. Intestines, liver, muscles and adipose tissue were collected for total RNA and protein isolation. Unfixed intestines were flushed with PBS using a syringe, embedded in Tissue-Tek (Sakura, 4583) and frozen in liquid nitrogen for immunohistochemical analysis.
Quantitative food consumption and fecal fat determination. For monitoring food intake and weight gain, adult mice were acclimatized to individual caging and to the HFD for a week, monitored for weight gain and their food intake daily. The daily food intake data were pooled for the following 7 days and the food intake was estimated (g/day). Biochemical assays. Plasma triglycerides concentrations were measured employing the Chol2 COBAS (03039773190) commercial kit (Roche). Blood glucose levels were measured using the One Touch Ultra 2 device (LifeScan Inc.).
Hepatic and lipoprotein lipase concentrations were measured as previously described 80 . Blood samples were always collected in the morning after 4 hours fasting. For glucose tolerance test, mice were given an intraperitoneal injection of 2 g/kg glucose, and blood glucose was subsequently measured at the indicated time points.
In vivo intestinal triglyceride absorption analysis. TIS7 SKMc15 dKO mice and WT littermates maintained on a RD were food-deprived for 4 h. Mice received a bolus (60 microliters per body weight through intragastric gavages) of olive oil, then they were sacrificed at indicated time points and intestines harvested to detect lipid accumulation using toluidine blue staining. The same experiment was repeated with animals fed with HFD for one week and their intestines were stained with oil red O. For quantitative studies, a bolus of 200 µl olive oil (Carapelli) containing 1 mCi (9,10-3H(N9))triolein (Perkin Elmer, NET431001MC) was orally administered to mice using an infusion cannula with a bulb end (Acufirm Ernst Kratz). Blood samples were collected 0, 1, and 2 h after the oral gavage for scintillation counter measurement of the absorbed serum 3H-triolein amount. To inhibit the clearance of plasma triacylglycerol, 100 µl of the surfactant tyloxapol (5% in PBS, Sigma-Aldrich, T8761) were administered through intraperitoneal injection 81 .
Antibodies, viral and cDNA constructs. Antibodies used for immunofluorescence and Western blot analysis of CD36
were purchased from AbD Serotec (MCA2748) and Abcam (ab36977) respectively. p44/42 MAPK (Erk1/2) and
Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) antibodies were from Cell Signaling Technology (9102, 9101), rabbit anti-β-catenin antibody was from Sigma (C2206) and mouse monoclonal anti-DLK antibody from Abcam (ab119930).
anti-Histone H4R3me2s antibody used for chromatin immunoprecipitation was purchased from Active Motif (61187).
For CD36 promoter activity assay, we used PGLCD36 construct kindly provided by Dr. Paul Shore (University of Manchester, UK). Luciferase reporter construct pTOPflash was a gift from Prof. H. Clevers (University of Utrecht, Holland). TIS7 construct used for luciferase assays was described previously 14 RNA collection for microarray analysis and quantitative RT-PCR. Tissues from animals fed for 3 weeks with HFD were snap frozen and stored at -80°C. Total RNA was isolated using the TRIzol reagent (Invitrogen, 15596026). RNA was then chloroform-extracted and precipitated with isopropanol. The yield and purity of RNA was determined by spectroscopic analysis; RNA was stored at -80°C until use.
RNA microarray analysis. Gene expression profiling analysis was performed by the Expression Profiling Unit at the Innsbruck Medical University according to the following protocol. For total RNA isolation, a combination of TRIreagent (MRC Inc., TR 118) and RNAeasy spin columns (Quiagene, 4380204) was used according to the manufacturers' protocols. RNA quantity and purity was determined by optical density measurements (OD260/280) and RNA integrity by using the 2100 Bioanalyzer (Agilent Technologies). Only high quality RNA was further processed. For Affymetrix GeneChip analysis 500 ng total RNA was processed to generate a biotinylated hybridization target using "One Cycle cDNA Synthesis" and "One Cycle Target Labelling" kits from Affymetrix (A10752030) according to the manufacturer's protocols. In brief, total RNA was reverse-transcribed into cDNA using an anchored oligo-dTT7-Primer, converted into double-stranded cDNA and purified with the "Affymetrix Sample Clean-up Kit". Thereafter, cRNA was generated by T7 polymerase-mediated in vitro transcription including a modified nucleotide for subsequent biotinylation. Following RNA purification, 20 μg of cRNA were fragmented at 95° using the Affymetrix fragmentation buffer, mixed with hybridization buffer containing hybridization controls and hybridized to the GeneChips (Mouse Genome 430 2.0). The arrays were stained and washed in an Affymetrix fluidic station 450. Fluorescence signals were recorded by an Affymetrix scanner 3000 and image analysis performed with the GCOS software. All further analyses were performed in R (http://www.rproject.org) using packages from the Bioconductor project (version 2.6) 83 . Functions from the affyPLM package were used for quality assessments of the microarrays and only good quality arrays were further analysed. GeneChip raw expression values were normalized and summarized using the GCRMA method 84 . p-values for significance of differential expression were calculated using the moderated t test 85 and adjusted for multiple hypothesis testing using the method from Benjamini and Hochberg 86 . Genes with an adjusted p-value < 0.05 were considered significantly differentially expressed. Microarray raw and pre-processed data has been deposited to Gene Expression Omnibus, accession number GSE27019. In vitro free fatty acid uptake and viral infection. Micelles were generated as recently described 69 The following radiolabeled 3H-labeled fatty acids were used: palmitic acid (16:0) and lignoceric acid (24:0) (American Radiolabeled Chemicals, ART 1986, ART 0865). MSCs were plated into 24-well culture dishes; at 80% confluence they were washed twice with PBS (ambient temperature) and incubated with 400 microlitres of lipid micelles containing 100,000 dpm of the indicated 3H-labeled lipids for 3 min. The cells were then washed three times with PBS and dissolved in 0.1mM NaOH. The associated radioactivity was determined by liquid scintillation counting. Data are expressed as the fractional uptake (the percentage of the total radioactivity applied to the cells which remains cellassociated following three washes with PBS).
Chromatin immunoprecipitation (ChIP). Chromatin was isolated from TIS7 WT and dKO formaldehyde-treated MEFs using the EpiSeeker Chromatin Extraction Kit (Abcam, ab117152) according to the manufacturer protocol. ChIP analyses were carried out as described previously 87 
